Cargando…

Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study

OBJECTIVES: Our aim was to perform a perfluorobutylpentane (F(4)H(5)) washout in conjunction with glaucoma drainage device (GDD) placement in patients with silicone oil (SO)-induced glaucoma. In this report we present our preliminary results concerning the effectiveness in clearing the SO and the sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandarakis, Stylianos A., Petrou, Petros, Doumazos, Spyridon, Chronopoulou, Konstantina, Doumazos, Leonidas, Halkiadakis, Ioannis, Georgalas, Ilias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599334/
https://www.ncbi.nlm.nih.gov/pubmed/37867479
http://dx.doi.org/10.4274/tjo.galenos.2023.95825
_version_ 1785125746575933440
author Kandarakis, Stylianos A.
Petrou, Petros
Doumazos, Spyridon
Chronopoulou, Konstantina
Doumazos, Leonidas
Halkiadakis, Ioannis
Georgalas, Ilias
author_facet Kandarakis, Stylianos A.
Petrou, Petros
Doumazos, Spyridon
Chronopoulou, Konstantina
Doumazos, Leonidas
Halkiadakis, Ioannis
Georgalas, Ilias
author_sort Kandarakis, Stylianos A.
collection PubMed
description OBJECTIVES: Our aim was to perform a perfluorobutylpentane (F(4)H(5)) washout in conjunction with glaucoma drainage device (GDD) placement in patients with silicone oil (SO)-induced glaucoma. In this report we present our preliminary results concerning the effectiveness in clearing the SO and the safety of the procedure. MATERIALS AND METHODS: Eight patients who previously underwent pars plana vitrectomy with SO tamponade due to retinal detachment were selected. Removal of SO was performed on average 10 months after initial surgery. All patients developed glaucoma with evidence of SO remnants in the anterior chamber (AC) and angle. Removal of the remaining SO with F(4)H(5) washout was performed in all cases with concomitant insertion of a GDD to treat the refractory glaucoma. Intraocular pressure (IOP), SO remnants, endothelial cell count, and need for glaucoma medications were evaluated up to 12 months after the surgical procedure. RESULTS: All patients had uneventful surgery with no major complications 12 months postoperatively. A marked reduction of SO remnants in the AC and angle was observed in all cases after surgery. There was a 60.9% decrease in mean IOP 12 months postoperatively (p<0.05) and the need for glaucoma medication was lower in all patients (mean topical medicines: 4 preoperatively vs. 0.75±0.89 postoperatively; p<0.05). Endothelial cell density showed no significant change (mean 2012±129 cells/mm(2) preoperatively vs. 1985±134 cells/mm(2) postoperatively; p>0.05), and there were no signs of corneal edema. CONCLUSION: F(4)H(5) is an effective emulsifier for removing SO remnants and may be safely used in conjunction with GDD placement in order to control IOP in eyes with silicone oil-induced glaucoma.
format Online
Article
Text
id pubmed-10599334
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-105993342023-10-26 Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study Kandarakis, Stylianos A. Petrou, Petros Doumazos, Spyridon Chronopoulou, Konstantina Doumazos, Leonidas Halkiadakis, Ioannis Georgalas, Ilias Turk J Ophthalmol Original Article OBJECTIVES: Our aim was to perform a perfluorobutylpentane (F(4)H(5)) washout in conjunction with glaucoma drainage device (GDD) placement in patients with silicone oil (SO)-induced glaucoma. In this report we present our preliminary results concerning the effectiveness in clearing the SO and the safety of the procedure. MATERIALS AND METHODS: Eight patients who previously underwent pars plana vitrectomy with SO tamponade due to retinal detachment were selected. Removal of SO was performed on average 10 months after initial surgery. All patients developed glaucoma with evidence of SO remnants in the anterior chamber (AC) and angle. Removal of the remaining SO with F(4)H(5) washout was performed in all cases with concomitant insertion of a GDD to treat the refractory glaucoma. Intraocular pressure (IOP), SO remnants, endothelial cell count, and need for glaucoma medications were evaluated up to 12 months after the surgical procedure. RESULTS: All patients had uneventful surgery with no major complications 12 months postoperatively. A marked reduction of SO remnants in the AC and angle was observed in all cases after surgery. There was a 60.9% decrease in mean IOP 12 months postoperatively (p<0.05) and the need for glaucoma medication was lower in all patients (mean topical medicines: 4 preoperatively vs. 0.75±0.89 postoperatively; p<0.05). Endothelial cell density showed no significant change (mean 2012±129 cells/mm(2) preoperatively vs. 1985±134 cells/mm(2) postoperatively; p>0.05), and there were no signs of corneal edema. CONCLUSION: F(4)H(5) is an effective emulsifier for removing SO remnants and may be safely used in conjunction with GDD placement in order to control IOP in eyes with silicone oil-induced glaucoma. Galenos Publishing 2023-10 2023-10-19 /pmc/articles/PMC10599334/ /pubmed/37867479 http://dx.doi.org/10.4274/tjo.galenos.2023.95825 Text en © Copyright 2023 by Turkish Ophthalmological Association | Turkish Journal of Ophthalmology, published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kandarakis, Stylianos A.
Petrou, Petros
Doumazos, Spyridon
Chronopoulou, Konstantina
Doumazos, Leonidas
Halkiadakis, Ioannis
Georgalas, Ilias
Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title_full Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title_fullStr Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title_full_unstemmed Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title_short Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study
title_sort combining perfluorobutylpentane (f(4)h(5)) with glaucoma drainage device implantation for silicone oil-induced glaucoma: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599334/
https://www.ncbi.nlm.nih.gov/pubmed/37867479
http://dx.doi.org/10.4274/tjo.galenos.2023.95825
work_keys_str_mv AT kandarakisstylianosa combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT petroupetros combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT doumazosspyridon combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT chronopouloukonstantina combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT doumazosleonidas combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT halkiadakisioannis combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy
AT georgalasilias combiningperfluorobutylpentanef4h5withglaucomadrainagedeviceimplantationforsiliconeoilinducedglaucomaapilotstudy